USA - NYSE:VEEV - US9224751084 - Common Stock
We assign a fundamental rating of 7 out of 10 to VEEV. VEEV was compared to 35 industry peers in the Health Care Technology industry. VEEV gets an excellent profitability rating and is at the same time showing great financial health properties. VEEV is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make VEEV suitable for growth and quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 10.12% | ||
ROE | 12.2% | ||
ROIC | 10.28% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 27.96% | ||
PM (TTM) | 27.29% | ||
GM | 75.59% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 22.1 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 5.57 | ||
Quick Ratio | 5.57 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 37.46 | ||
Fwd PE | 32.81 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 34.44 | ||
EV/EBITDA | 39.24 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
279.08
+4.5 (+1.64%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 37.46 | ||
Fwd PE | 32.81 | ||
P/S | 15.41 | ||
P/FCF | 34.44 | ||
P/OCF | 33.9 | ||
P/B | 6.89 | ||
P/tB | 7.42 | ||
EV/EBITDA | 39.24 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 10.12% | ||
ROE | 12.2% | ||
ROCE | 12.31% | ||
ROIC | 10.28% | ||
ROICexc | 203.55% | ||
ROICexgc | N/A | ||
OM | 27.96% | ||
PM (TTM) | 27.29% | ||
GM | 75.59% | ||
FCFM | 44.74% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Debt/EBITDA | 0 | ||
Cap/Depr | 53.26% | ||
Cap/Sales | 0.71% | ||
Interest Coverage | 250 | ||
Cash Conversion | 155.11% | ||
Profit Quality | 163.97% | ||
Current Ratio | 5.57 | ||
Quick Ratio | 5.57 | ||
Altman-Z | 22.1 |